Clinical Trial Update: Post Marketing Surveillance To Observe Safety And Efficacy Of Duavive

View source ↗

Summary

Post-marketing surveillance trial to observe safety and efficacy of Duavive in severe vasomotor symptoms of menopause has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause-related Vasomotor Symptoms

Drugs mentioned

• Duavive (bazedoxifene/conjugated estrogens)

Snippet

Sponsor: Pfizer | Conditions: Severe Vasomotor Symptom Associated With Menopause | Status: COMPLETED | Results posted: 2021-08-05